IMMUNOTHERAPY IN HEAD AND NECK CANCER: ADVANCES IN IMMUNE CHECKPOINT INHIBITION AND TARGETED IMMUNOTHERAPIES FOR ENHANCED TREATMENT OUTCOMES. Med. Ins. J. 2024, 2 (02), 11-20.